CS 43001
Alternative Names: CS-43001Latest Information Update: 03 Nov 2020
At a glance
- Originator Chipscreen Biosciences
- Class Antipsoriatics; Small molecules
- Mechanism of Action TYK2 kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Psoriasis
Most Recent Events
- 21 Oct 2020 Preclinical trials in Psoriasis in China (unspecified route) before October 2020 (Chipscreen Biosciences pipeline, October 2020)